{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:33:22Z","timestamp":1790393602566,"version":"4.1.0"},"reference-count":84,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>An imbalance in circulating factors that regulate blood vessel formation and health, referred to as angiogenic factors, plays a central role in the pathogenesis of preeclampsia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONTENT<\/jats:title>\n                    <jats:p>Several studies have demonstrated a strong association between altered circulating angiogenic factors and preeclampsia. These factors include circulating antiangiogenic proteins such as soluble fms-like tyrosine kinase 1 and soluble endoglin and proangiogenic protein such as placental growth factor. Abnormalities in these circulating angiogenic factors are not only present during clinical disease, but also antedate clinical signs and symptoms by several weeks. These alterations are particularly prominent in patients who present with preeclamptic signs and symptoms prematurely and\/or in patients with severe preeclampsia. The availability of automated platforms for the rapid measurement of circulating angiogenic proteins in blood samples has now allowed researchers and clinicians to evaluate the utility of these assays in the diagnosis of the disease, in the stratification of patients in clinical trials, or in the monitoring of therapies. In this review we highlight the various studies that have been performed, with a focus on large validation studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY<\/jats:title>\n                    <jats:p>Measurement of circulating angiogenic proteins for the diagnosis and prediction of preeclampsia is still at an early stage but is rapidly evolving. Standardization across the various automated platforms and prospective studies that demonstrate clinical utility are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1373\/clinchem.2011.169094","type":"journal-article","created":{"date-parts":[[2012,3,20]],"date-time":"2012-03-20T00:55:04Z","timestamp":1332204904000},"page":"837-845","source":"Crossref","is-referenced-by-count":109,"title":["The Promise of Angiogenic Markers for the Early Diagnosis and Prediction of Preeclampsia"],"prefix":"10.1093","volume":"58","author":[{"given":"Henning","family":"Hagmann","sequence":"first","affiliation":[{"name":"Renal Division, Department of Medicine and Centre for Molecular Medicine, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Thadhani","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Benzing","sequence":"first","affiliation":[{"name":"Renal Division, Department of Medicine and Centre for Molecular Medicine, University of Cologne, Cologne, Germany"},{"name":"Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Ananth","family":"Karumanchi","sequence":"first","affiliation":[{"name":"Howard Hughes Medical Institute and Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Stepan","sequence":"first","affiliation":[{"name":"Department of Obstetrics, University Hospital Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,5,1]]},"reference":[{"key":"2020022705141390200_B1","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"key":"2020022705141390200_B2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0002-9378(98)70146-2","article-title":"Prevention of preeclampsia: a big disappointment","volume":"179","author":"Sibai","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B3","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(00)02800-2","article-title":"Pre-eclampsia","volume":"356","author":"Walker","year":"2000","journal-title":"Lancet"},{"key":"2020022705141390200_B4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0301-2115(00)00383-3","article-title":"Management and monitoring of severe preeclampsia","volume":"96","author":"Bolte","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2020022705141390200_B5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"2020022705141390200_B6","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/S0140-6736(00)05112-6","article-title":"Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births","volume":"357","author":"Smith","year":"2001","journal-title":"Lancet"},{"key":"2020022705141390200_B7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ncpneph0623","article-title":"Hypertension in pregnancy: an emerging risk factor for cardiovascular disease","volume":"3","author":"Garovic","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"2020022705141390200_B8","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease","volume":"123","author":"Powe","journal-title":"Circulation"},{"key":"2020022705141390200_B9","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"Roberts","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B10","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1681\/ASN.2007020255","article-title":"The glomerular injury of preeclampsia","volume":"18","author":"Stillman","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2020022705141390200_B11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1172\/JCI17423","article-title":"Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases","volume":"111","author":"Eremina","year":"2003","journal-title":"J Clin Invest"},{"key":"2020022705141390200_B12","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"key":"2020022705141390200_B13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jnci\/djm311","article-title":"A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib","volume":"100","author":"Patel","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"2020022705141390200_B14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"2020022705141390200_B15","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1210\/jc.2002-021942","article-title":"Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia","volume":"88","author":"Koga","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022705141390200_B16","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1210\/jc.2003-030528","article-title":"Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences","volume":"88","author":"Tsatsaris","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022705141390200_B17","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.RES.0000147365.86159.f5","article-title":"Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia","volume":"95","author":"Ahmad","year":"2004","journal-title":"Circ Res"},{"key":"2020022705141390200_B18","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1073\/pnas.90.22.10705","article-title":"Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor","volume":"90","author":"Kendall","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020022705141390200_B19","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1095\/biolreprod59.6.1540","article-title":"A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation","volume":"59","author":"Clark","year":"1998","journal-title":"Biol Reprod"},{"key":"2020022705141390200_B20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/01.grf.0000160313.82606.d7","article-title":"Circulating angiogenic factors in preeclampsia","volume":"48","author":"Levine","year":"2005","journal-title":"Clin Obstet Gynecol"},{"key":"2020022705141390200_B21","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1582-4934.2009.00820.x","article-title":"Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model","volume":"14","author":"Bergmann","year":"2010","journal-title":"J Cell Mol Med"},{"key":"2020022705141390200_B22","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/HYPERTENSIONAHA.107.096594","article-title":"Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression","volume":"50","author":"Gilbert","year":"2007","journal-title":"Hypertension"},{"key":"2020022705141390200_B23","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1073\/pnas.1011293108","article-title":"Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model","volume":"108","author":"Kumasawa","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020022705141390200_B24","doi-asserted-by":"crossref","first-page":"396 e1","DOI":"10.1016\/j.ajog.2006.12.024","article-title":"The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice","volume":"196","author":"Lu","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B25","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.ki.5002175","article-title":"Uteroplacental ischemia results in proteinuric hypertension and elevated sFlt-1","volume":"71","author":"Makris","year":"2007","journal-title":"Kidney Int"},{"key":"2020022705141390200_B26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14767050400028816","article-title":"Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia","volume":"17","author":"Chaiworapongsa","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2020022705141390200_B27","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1373\/clinchem.2004.036715","article-title":"Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia","volume":"50","author":"Hertig","year":"2004","journal-title":"Clin Chem"},{"key":"2020022705141390200_B28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"2020022705141390200_B29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"2020022705141390200_B30","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"2020022705141390200_B31","doi-asserted-by":"crossref","first-page":"152 e1","DOI":"10.1016\/j.ajog.2010.08.049","article-title":"Circulating angiogenic and antiangiogenic factors in women with eclampsia","volume":"204","author":"Vaisbuch","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B32","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/S0049-3848(11)70020-2","article-title":"New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications","volume":"127","author":"Ahmed","year":"2011","journal-title":"Thromb Res"},{"key":"2020022705141390200_B33","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/jc.2003-031244","article-title":"First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia","volume":"89","author":"Thadhani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022705141390200_B34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejogrb.2004.11.015","article-title":"Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia","volume":"122","author":"Staff","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2020022705141390200_B35","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCULATIONAHA.109.895458","article-title":"Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension","volume":"122","author":"Noori","journal-title":"Circulation"},{"key":"2020022705141390200_B36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050701830480","article-title":"A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate","volume":"21","author":"Romero","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2020022705141390200_B37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1067\/mob.2003.111","article-title":"Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies","volume":"188","author":"Taylor","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jama.293.1.77","article-title":"Urinary placental growth factor and risk of preeclampsia","volume":"293","author":"Levine","year":"2005","journal-title":"JAMA"},{"key":"2020022705141390200_B39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijgo.2005.02.008","article-title":"Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin a, fibronectin and uterine artery doppler velocimetry","volume":"89","author":"Madazli","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"2020022705141390200_B40","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/00016340802253759","article-title":"Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia","volume":"87","author":"De Vivo","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2020022705141390200_B41","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/AOG.0b013e3181719b7a","article-title":"Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors","volume":"111","author":"Lim","year":"2008","journal-title":"Obstet Gynecol"},{"key":"2020022705141390200_B42","doi-asserted-by":"crossref","first-page":"161 e1","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia","volume":"202","author":"Verlohren","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B43","doi-asserted-by":"crossref","first-page":"266 e1","DOI":"10.1016\/j.ajog.2008.06.069","article-title":"First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia","volume":"199","author":"Baumann","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B44","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.AOG.0000265804.09161.0d","article-title":"Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth","volume":"109","author":"Smith","year":"2007","journal-title":"Obstet Gynecol"},{"key":"2020022705141390200_B45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/HYPERTENSIONAHA.107.087700","article-title":"Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia","volume":"50","author":"Rana","year":"2007","journal-title":"Hypertension"},{"key":"2020022705141390200_B46","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.placenta.2008.09.004","article-title":"Screening for placental insufficiency in high-risk pregnancies: is earlier better?","volume":"29","author":"Costa","year":"2008","journal-title":"Placenta"},{"key":"2020022705141390200_B47","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/HYPERTENSIONAHA.108.127977","article-title":"First-trimester prediction of hypertensive disorders in pregnancy","volume":"53","author":"Poon","year":"2009","journal-title":"Hypertension"},{"key":"2020022705141390200_B48","doi-asserted-by":"crossref","first-page":"239 e1","DOI":"10.1016\/j.ajog.2006.10.909","article-title":"Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia","volume":"196","author":"Vatten","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B49","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"Kusanovic","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2020022705141390200_B50","doi-asserted-by":"crossref","first-page":"244 e1","DOI":"10.1016\/j.ajog.2007.06.030","article-title":"Angiogenic factors for the prediction of preeclampsia in high-risk women","volume":"197","author":"Moore Simas","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B51","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/HYPERTENSIONAHA.111.181735","article-title":"Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy","volume":"59","author":"Perni","year":"2012","journal-title":"Hypertension"},{"key":"2020022705141390200_B52","doi-asserted-by":"crossref","first-page":"e13263","DOI":"10.1371\/journal.pone.0013263","article-title":"Soluble fms-like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies","volume":"5","author":"Powers","year":"2010","journal-title":"PLoS One"},{"key":"2020022705141390200_B53","doi-asserted-by":"crossref","first-page":"268 e1","DOI":"10.1016\/j.ajog.2008.06.071","article-title":"Serum inhibin a and angiogenic factor levels in pregnancies with previous preeclampsia and\/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia?","volume":"199","author":"Sibai","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/uog.5184","article-title":"Predictive value of angiogenic factors and uterine artery doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction","volume":"31","author":"Crispi","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2020022705141390200_B55","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijgo.2008.02.016","article-title":"Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery doppler velocimetry","volume":"102","author":"Diab","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"key":"2020022705141390200_B56","doi-asserted-by":"crossref","first-page":"326 e1","DOI":"10.1016\/j.ajog.2006.11.002","article-title":"Identification of patients at risk for early onset and\/or severe preeclampsia with the use of uterine artery doppler velocimetry and placental growth factor","volume":"196","author":"Espinoza","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B57","doi-asserted-by":"crossref","first-page":"175 e1","DOI":"10.1016\/j.ajog.2007.08.052","article-title":"Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion","volume":"198","author":"Stepan","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B58","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.HYP.0000258404.21552.a3","article-title":"Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion","volume":"49","author":"Stepan","year":"2007","journal-title":"Hypertension"},{"key":"2020022705141390200_B59","doi-asserted-by":"crossref","first-page":"28 e1","DOI":"10.1016\/j.ajog.2007.04.010","article-title":"Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy","volume":"197","author":"Salahuddin","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B60","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ajog.2004.03.043","article-title":"Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award","volume":"190","author":"Chaiworapongsa","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B61","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3109\/14767058.2011.556204","article-title":"Fetal endothelium dysfunction is associated with circulating maternal levels of sE-selectin, sVCAM1, and sFlt-1 during pre-eclampsia","volume":"24","author":"Veas","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2020022705141390200_B62","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/01.AOG.0000264552.85436.a1","article-title":"Placental growth factor and soluble fms-like tyrosine kinase-1 in early-onset and late-onset preeclampsia","volume":"109","author":"Wikstrom","year":"2007","journal-title":"Obstet Gynecol"},{"key":"2020022705141390200_B63","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ajog.2004.12.052","article-title":"Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia","volume":"192","author":"Buhimschi","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B64","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/HYPERTENSIONAHA.108.124115","article-title":"Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study","volume":"53","author":"Herse","year":"2009","journal-title":"Hypertension"},{"key":"2020022705141390200_B65","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/pd.2203","article-title":"The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia","volume":"29","author":"Kim","year":"2009","journal-title":"Prenat Diagn"},{"key":"2020022705141390200_B66","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1471-0528.2009.02453.x","article-title":"Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia","volume":"117","author":"Masuyama","journal-title":"BJOG"},{"key":"2020022705141390200_B67","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.aanat.2008.08.002","article-title":"Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by pre-eclampsia","volume":"190","author":"Tripathi","year":"2008","journal-title":"Ann Anat"},{"key":"2020022705141390200_B68","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1291\/hypres.30.151","article-title":"Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia","volume":"30","author":"Ohkuchi","year":"2007","journal-title":"Hypertens Res"},{"key":"2020022705141390200_B69","doi-asserted-by":"crossref","first-page":"469.e1","DOI":"10.1016\/j.ajog.2011.06.058","article-title":"Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays","volume":"205","author":"Benton","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B70","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/hr.2010.15","article-title":"Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia","volume":"33","author":"Ohkuchi","year":"2010","journal-title":"Hypertens Res"},{"key":"2020022705141390200_B71","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.clinbiochem.2010.02.010","article-title":"Multicenter evaluation of the first automated elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia","volume":"43","author":"Schiettecatte","year":"2010","journal-title":"Clin Biochem"},{"key":"2020022705141390200_B72","doi-asserted-by":"crossref","first-page":"40 e1","DOI":"10.1016\/j.ajog.2009.07.025","article-title":"Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study","volume":"202","author":"Sunderji","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B73","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/10641950903322881","article-title":"Measurement of sVEGF R1 and PlGF in serum: comparing prototype assays from Beckman Coulter, Inc. to R&D systems microplate assays","volume":"30","author":"Wothe","year":"2011","journal-title":"Hypertens Pregnancy"},{"key":"2020022705141390200_B74","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/CS20110097","article-title":"Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia","volume":"122","author":"Verlohren","year":"2012","journal-title":"Clin Sci"},{"key":"2020022705141390200_B75","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1067\/mob.2001.114484","article-title":"Perinatal regionalization and neonatal mortality in North Carolina, 1968\u20131994","volume":"184","author":"Bode","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B76","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1542\/peds.109.5.745","article-title":"Mortality in low birth weight infants according to level of neonatal care at hospital of birth","volume":"109","author":"Cifuentes","year":"2002","journal-title":"Pediatrics"},{"key":"2020022705141390200_B77","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1067\/mob.2000.107357","article-title":"Association between level of delivery hospital and neonatal outcomes among South Carolina Medicaid recipients","volume":"183","author":"Sanderson","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B78","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"2020022705141390200_B79","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.111.034793","article-title":"Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"124","author":"Thadhani","year":"2011","journal-title":"Circulation"},{"key":"2020022705141390200_B80","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.106.660134","article-title":"Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1","volume":"115","author":"Cudmore","year":"2007","journal-title":"Circulation"},{"key":"2020022705141390200_B81","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0030-1262827","article-title":"[Use of angiogenic factors (sFlt-1\/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: first experience]","volume":"214","author":"Stepan","year":"2010","journal-title":"Z Geburtshilfe Neonatol"},{"key":"2020022705141390200_B82","doi-asserted-by":"crossref","first-page":"58 e1","DOI":"10.1016\/j.ajog.2011.07.037","article-title":"The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients","volume":"206","author":"Verlohren","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"2020022705141390200_B83","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3109\/14767058.2011.589932","article-title":"Maternal plasma concentrations of angiogenic\/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia","volume":"24","author":"Chaiworapongsa","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2020022705141390200_B84","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/58\/5\/837\/32657910\/clinchem0837.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/58\/5\/837\/32657910\/clinchem0837.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T05:17:47Z","timestamp":1582780667000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/58\/5\/837\/5620658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,1]]},"references-count":84,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,1]]},"published-print":{"date-parts":[[2012,5,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2011.169094","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,5,1]]},"published":{"date-parts":[[2012,5,1]]}}}